Stroke rehabilitation is an evolving field that embraces a holistic and patient-centered perspective, recognizing that the effects of a stroke extend beyond physical limitations. Cognitive rehabilitation, a crucial aspect of stroke recovery, focuses on addressing memory deficits, attention difficulties, and executive functioning challenges that may arise. Technological advancements have introduced innovative tools, such as virtual reality and robotic-assisted devices, to enhance the effectiveness of stroke rehabilitation by providing engaging and targeted interventions. Community reintegration is another key component, emphasizing the transition of individuals back into their homes and communities. Stroke survivors often benefit from participation in support groups and community-based programs to foster social connections and share experiences. As the understanding of neuroplasticity advances, rehabilitation strategies continue to evolve, emphasizing the brain's ability to reorganize and adapt to promote recovery. Stroke rehabilitation is a dynamic and collaborative process, involving not only healthcare professionals but also the active participation of individuals and their families in the journey toward optimal recovery and rehabilitation.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation